We developed a post-embedding immunogold labeling procedure for the ultrastructural localization of the HTLV-I gag proteins p19 and p24 by the use of monodonal antibodies (MAb).
Introduction
The first human retrovirus described was human T-cell leukemia (2, 12, 14, 15, 23, 24) or polyclonal sera from patients with ATLL (7, 9, 10, 12, 14, 15, 23, 24 in LA White. Section was stained with anti-HTLV-l pl9bfollowed by goatanti-mouse lgG coupled to 10-nm gold particles.
Original magnification x 40,000. Bar = 0.5 tm. 
Results
In all samples, HTLV-I virions were found mainly in the extracellu- Figure  4 ). HTLV-I virions appeared as electron-dense particles of variable size located in the extracellular space near the cell membrane.
The virions lacked any further morphological detail and were sometimes intermingled with cell in LA White. Section was stained with anti-HTLV-l pl9b followed by goat anti-mouse lgG coupled to 10-nm gold particles.
Original magnification x 40,000. Bar = 0.5 tm. Figure 2 . HTLV-l virions fixed in 1% glutaraldehyde, post-fixed in 1% osmium tetroxide, and embedded in LA White. Section was stained with anti-HTLV-l pl9b followed by goat anti-mouse lgG coupled to 10-nm gold particles.
Original magnification x 80,000. Bar = 0.5 tm.
Figure a HTLV-l virions fixed in 1% glutaraldehyde, post-fixed in 1% osmium tetroxide, and embedded in LA White. Section was stained with anti-HTLV-l p24a followed by goat anti-mouse lgG coupled to 10-nm gold particles.
Original magnification x 40,000. Bar = 0.5 tm. .., .
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HTLV-I IMMUNOHIS1DCHEMISTRY 1 and 2) , whereas anti-HTLV-I p24a failed to give a positive staining result, as demonstrated by the absence of gold labeling on the virions ( Figure  3 ). In unosmicated LR White-embedded specimens the staining resuit was equal to that ofosmicated samples. Anti-I-lTD/-I pl9b gave a positive staining result demonstrated by strong labeling of HTLV-I virions (Figure 4) 7 and 8) . Both p19 and p24 were found to be co-localized on the same viral particle. Antigenic sites of p24 could easily be identified by the strong labeling with 5-nm gold particles, whereas the presence ofpl9 was visualized by the labeling with 10-nm gold particles.
The result was independent of the sequence of the application ofthe primary antibodies, regardless ofwhether anti-HTIV-I pl9b or anti-HTLV-I p24a was used as the first primary antibody.
Furthermore, the result was the same for the procedure with goat anti-mouse IgG coupled to 5 -nm gold particles as the first secondary antibody and for the procedure with goat anti-mouse IgG coupled to 10-nm gold particles as the first secondary antibody.
Discussion
In immunohistochemistry several factors, i.e., the method of fixation, the choice of resin, and the selection of immunological reagents, must be considered to play a decisive role in the successful localization of antigenic sites.
With regard to fixation, a compromise has to be found between been known from previous investigations (7, 9, 10, 12, 14, 15, 23, 24 In two previous studies the application of a monoclonal antibody against p19 has been reported, but exclusively in a pre- First side of the section was stained with anti-HTLV-l p24a followed by goat anti-mouse lgG coupled to 5-nm gold particles; second side of the section was stained with anti-HTLV-l pl9b followed by goat antimouse lgG coupled to 10-nm gold particles.
Original magnification x 105,000. Bar = 0.1 sm.
Figure a HTLV-I virions fixed in 1% glutaraldehyde
and embedded in Lowicryl K4M. Double immunogold labeling. First side ofthe section was stained with anti-HTLV-l pl9b followed by goat anti-mouse lgG coupled to 10-nm gold particles; second side of the section was stained with anti-HTLV-l p24a followed by goat anti-mouse lgG coupled to 5-nm gold particles.
Original magnification x 105,000. Bar 0.1 tm.
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